Alexandria Real Estate Equities

Landlord and Developer of Choice to the Life Science Industry®, the largest owner, cluster developer, and pre-eminent first-in-class international real estate investment trust focused principally on the ownership, operation, management, redevelopment, selective development and acquisition of properties containing office/laboratory space. Alexandria is the leading provider of real estate to the life science industry, and has an outstanding ten-year track record as a NYSE listed company with an approximate $5.6 billion total market capitalization (as of September 30, 2007). Alexandria provides high-quality real estate, technical infrastructure, services and capital to the broad and diverse life science sector. Client tenants include institutional (universities and independent not-for-profit institutions), pharmaceutical, biotechnology, medical device, life science product, service, biodefense and translational medicine entities, as well as governmental agencies. Alexandria’s international operating platform is based on the principle of “clustering,” with assets and operations strategically located in key life science hub markets. 

Archer Daniels Midland

is a world leader in agricultural processing. ADM is one of the world's largest processors of soybeans, corn, wheat and cocoa. ADM is also a leader in the production of soy meal and oil, ethanol, corn sweeteners and flour. In addition, ADM produces value-added food and feed ingredients. Headquartered in Decatur, Illinois, ADM has over 26,000 employees, more than 250 processing plants and net sales for the fiscal year ended June 30, 2004 of $36.2 billion. 

Bayer CropScience,

a subsidiary of Bayer AG with annual sales of about EUR 5.7 billion, is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and plant biotechnology. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of about 20,000 and is represented in more than 120 countries, ensuring proximity to dealers and consumers. 

Celgene

is a multinational integrated biopharmaceutical company that is engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immunological diseases through regulation of genomic and proteomic targets. Driving commercial success and profitability are marketed products, which include REVLIMID® (lenalidomide), and THALOMID® (thalidomide) among others. Celgene has built a commercialization, development, and discovery platform that integrates both small-molecule and cell-based therapies and spans the key functions required to generate a broad, deep and diverse pipeline of new therapeutics.  

DSM

is active worldwide in life science and nutritional products, performance materials and industrial chemicals. The company creates innovative products and services that help improve the quality of life. DSM’s products are being applied in a wide range of end markets and applications such as human and animal nutrition and health, cosmetics, pharmaceuticals, automotive and transport, coatings, housing and electrics & electronics (E&E). The group has annual sales of approximately EUR 8 billion and employs in the region of 25,000 people around the world. DSM ranks amoung the global leaders in many of its fields. DSM is headquartered in the Netherlands, with locations in Europe, Asia and the Americas. 

Fonterra

Co-operative Group Ltd is a leading multinational dairy company, owned by 11,600 New Zealand dairy farmers. Fonterra the world’s largest exporter of dairy products, exporting 95 percent of our production. Their global supply chain encompasses our shareholders’ farms in New Zealand through to customers and consumers in 140 countries. Collecting over 13 billion liters of milk a year, we manufacture and market over 2 million tons of dairy products annually, making us the world’s leader in large-scale milk procurement, processing and management. Their ingredients business is the largest dairy ingredients operation in the world, manufacturing and marketing more than 1,000 ingredient products to the international food industry under the NZMP® brand. Fonterra Brands, our consumer business has some of the world’s best-known dairy brands, including Anchor®, Anlene®, Anmum®, Tip Top®, Fresh ‘n Fruity® and Mainland®.  

H. Lundbeck A/S

based in Copenhagen, Denmark is a global specialty pharmaceutical company engaged in the research, development, production, marketing and sale of drugs targeting the central nervous system.  

Henkel KGaA

is a leader with brands and technologies that make people's lives easier, better and more beautiful. The Henkel Group operates in three strategic business areas: Home Care, Personal Care, and Adhesives, Sealants and Surface Treatment. In fiscal 2003, the Henkel Group generated sales of $9.44 billion and an operating profit (EBIT) of $706 million. 50,000 employees work for the Henkel Group worldwide. People in 125 countries around the world trust in brands and technologies from Henkel. 

International Business Machines Corporation (IBM)

is a world leader in developing information technology and infrastructure solutions for the healthcare and life science industries. Through IBM Healthcare & Life Sciences we create, support and enable leading-edge technology in the marketplace; we bring world-class solutions and services that can help enable sustainable growth for pharmaceutical research, biotechnology, genomics, healthcare and the life sciences industries. IBM Business Partners provide leading application and services to deliver innovation and to change the competitive landscape 

Invitrogen

provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen’s own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology—placing Invitrogen’s products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. 

Kraft Foods

is one of the world’s largest food and beverage companies, with 2006 net revenues of more than $34 billion. For more than 100 years, Kraft has offered consumers delicious and wholesome foods that fit the way they live. Millions of times a day, in more than 150 countries, consumers reach for their favorite Kraft brands. Headquartered in Northfield, Illinois, the company has more than 90,000 employees and over 150 manufacturing and processing facilities worldwide.  

Mitsubishi Corporation,

headquartered in Tokyo is Japan’s largest general trading company (sogo shosha) and one of the world's most diverse enterprises, with 804 subsidiaries and affiliates and a global network of 145 offices, 36 of which are in Japan. Together with its over 500 group companies, MC employs a multinational workforce of approximately 48,000 people. MC has long been engaged in business with customers around the world in virtually every industry, including energy, metals, machinery, chemicals, food and general merchandise. The company's extensive network and wide-ranging activities give it a decisive edge in gathering the timely, accurate market information vital to the success of its customers and partners.
 

Mitsubishi Tanabe Pharma Corporation,

one of the leading Japanese pharmaceutical companies, specializes in developing and marketing pharmaceutical products in the fields of cardiovascular and metabolic diseases, brain and nerve diseases, and renal and urinary system diseases. The Company, established through the merger of Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation in October 1, 2007, drives for the expansion of its operations and the reinforcement of its future growth with the aim of becoming a global research-driven pharmaceutical company and taking on challenge of new business opportunities. Mitstubishi Tanabe Pharma Corporation is committed to protect the health of people around the world and contribute to comfortable lifestyles through creating pharmaceuticals. For more information, please visit the web site at www.mt-pharma.com.jp. 

Monsanto

is the world’s leading agricultural company focused on improving farmer productivity and reducing the impact of agriculture on the environment. Monsanto’s technology and products help farmers grow better food, feed, fuel and fiber crops. Monsanto leverages both biotech traits and molecular breeding capabilities to produce value enhanced seeds, grown throughout the world.  

Nanshing Color & Chemical Co. Ltd. and Nanco Electronics Supply Ltd.

is a Greater China trading, advisory and investment firm with headquarters in Hong Kong and offices throughout China and Taiwan. The firm has been assisting major international corporations conduct business in Greater China since 1950, and also strategically invests abroad to capture new trends, synergies and growth areas. 

Nestlé

has been a leading food manufacturer and major purchaser of agricultural raw material for more than 130 years. Today, Nestlé is the world's largest and most diversified food company, with over 500 factories around the globe producing food products for every stage of life. The company has gained vast experience through its scientific research into the nutritional needs and food preferences of consumers of all ages. No other food company invests as much in fundamental and applied research.
 

Novartis Venture Funds

invests in enterprises characterized by outstanding entrepreneurs and management teams developing innovative technologies with the potential of disrupting an existing or creating a new market and delivering significant patient benefits. Our investments range from early startup companies and Series A investment, which we intend to support through follow-on rounds, to more advanced private companies active in Life Sciences. Our key interest is in new therapeutics and platform technologies which we complement with investments in medical devices, diagnostics/ bio-markers and drug delivery technologies. Over the existence of the Fund since 1997, it has made a more then 100 equity investments. 30 profitable exists have been realized, and 60 private companies are still within the portfolio. The Novartis Venture Fund is an evergreen fund and has more than $650 million under management. For more information, please refer to www.venturefunds.novartis.com 

Novo A/S

is the holding and investment company of the Novo Group and is wholly owned by the Novo Nordisk Foundation. Novo A/S is an active and independent player with life science venture capital and has invested directly in more than 30 portfolio companies through North America and Europe since year 2000. Novo A/S also holds significant shareholdings in the publicly listed Novo Nordisk A/S and Novozymes A/S.
 

OLYMPUS

launched its business in 1919 and today enjoys a reputation for excellence in digital cameras as well as endoscopes, microscopes, and other medical equipment developed under the concept of opto-digital technology, which is a fusion of traditional optical and advanced digital technologies. OLYMPUS also offers the broadest standardized line of random access chemistry-immuno analyzers, along with lab automation systems, comprehensive patient safety systems, blood bank analyzers, and reagents. In recent years, OLYMPUS has been channeling its energies into developing business operations for human genome analysis systems and regenerative medicine to develop operations in the medical life science business.  

Procter & Gamble Pharmaceuticals (P&GP),

a division of The Procter & Gamble Company (NYSE: PG), has successfully developed and marketed a wide range of prescription products since the 1980s, including Actonel®, Asacol®, Enablex®, Entex®, Dantrium®, Didronel®, Macrobid®, and Ziac®. P&GP employs a Connect & Develop model for new product development and in-licenses or acquires 100% of its new drug candidates from biotech and pharmaceutical industry relationships. P&GP is committed to leveraging this model to build brands to address unmeet needs in the areas of gastrointestinal, musculoskeletal and women’s health. The P&GP community consists of more than 3,000 employees working in over 22 countries worldwide. For more information on P&GP and its prescription product portfolio, please visit www pgpharma.com Three billion times a day, P&G brands touch the lives of people around the world. P&G has one of the strongest portfolios of quality, leadership brands in consumer health and wellness, including Align®, Always®, Crest®, Metamucil®, Oral-B®, Pepto-Bismol®, Prilosec OTC®, Scope®, Tampax®, and Vicks®, in addition to its trusted consumer brands, including Ariel®, Braun®, Bounty®, Charmin®, Dawn®, Downy®, Duracell®, Folgers®, Gillette®, Head & Shoulders®, Iams®, Lenor®, Mach3®, Olay®, Pantene®, Pampers®, Pringles®, Tide®, Wella®, and Whisper®. The P&G community consists of over 135,000 employees working in over 80 countries worldwide. Please visit www.pg.com for the latest news and in-depth information about P&G and its brands. 

Quintiles Transnational

is the world’s leading provider of high quality development (Quintiles), commercialization (Innovex) and partnering (NovaQuest) services to the pharmaceutical, biotechnology, and healthcare industries. The 17,000 experienced and innovative professionals in the Quintiles family of companies improve healthcare worldwide by helping customers bring new medicines to market faster.  

SK Corporation,

founded in 1962, started as Korea's first oil refining company. Following the organization's restructuring to enhance competitiveness, SK Corporation has become the leading oil refiner in Korea with a 33.8% share of the domestic market. Through its subsidiary SK Bio-Pharmaceuticals, SK Corporation has been engaged in the innovative discovery of novel therapeutic compounds in the field of neuroscience in order to treat problems of epilepsy, depression, anxiety, Parkinson's, anti-psychotic and neurodegenerative disorders. In addition to the CNS area of research, SK Bio-Pharmaceuticals is working in the discovery of novel therapeutic compounds in the area of cancer and metabolic disease.
 

Tate & Lyle

is a world leading manufacturer of renewable food and industrial ingredients. It uses innovative technology to transform corn and sugar into value-added ingredients for customers in the food, beverage, pharmaceutical, cosmetic, paper, packaging and building industries. The Company is a leader in cereal sweeteners and starches, sugar refining, value added food and industrial ingredients, and citric acid. Tate & Lyle is the world number-one in industrial starches and is the sole manufacturer of SPLENDA® Sucralose.

Headquartered in London, Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. In the US its ADRs trade under TATYY. The Company operates more than 50 production facilities throughout Europe, the Americas, and Southeast Asia. In the year ending March 31, 2007, it employed 6,900 people in its subsidiaries with a further 2,300 employed in joint ventures. Sales in the year to March 31, 2007 totalled £4.0 billion. Additional information can be found at www.tateandlyle.com.SPLENDA® is a trademark of McNeil Nutritionals, LLC.  

The Siegfried Group

is a globally active company concentrating on pharmaceutical and natural products, with locations in Switzerland, Germany and the USA. The Group employs approximately 900 people and realized a turnover of CHF 321 million in 2004. The Siegfried Division, which comprises the Group's pharmaceutical activities, is organized into three business units: Siegfried Actives develops and produces Active Pharmaceutical Ingredients (APIs) for innovator, specialty and generic pharmaceutical companies, Siegfried Generics develops and produces generic pharmaceuticals and Siegfried Biologics develops and manufactures biotechnology-based pharmaceutical active substances. The Sidroga Division develops and markets high-quality, plant-based natural medicines and wellness products, particularly medicinal and wellness teas carrying the Sidroga label.
 

Unilever

is a major manufacturer and marketer of a broad range of foods, soaps, detergents and personal products through such brands as Lipton, Slim-Fast, Good Humor-Breyers, Ben & Jerry's, Bertolli, Knorr, Hellmann's, Dove, Lux, Snuggle, Thermasilk, all and Axe. Originally formed in 1930 from parent companies founded in the mid-19th century, it invests considerable resources, about $1 billion in 200 4 , into scientific research and product development. The Unilever group operates through approximately 500 companies in 90 countries around the world, and employs over 200,000 worldwide.